Georgetown Lombardi Visiting Professor and Grand Rounds Lecture Series: “Lung Cancer Screening Ten Years Post-USPSTF Recommendation: Thinking Outside the Clinic to Address Screening Disparities and Low Uptake”
Title: “Lung Cancer Screening Ten Years Post-USPSTF Recommendation: Thinking Outside the Clinic to Address Screening Disparities and Low Uptake”
Presented by:
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN
Professor of Oncology, Georgetown University
Co-leader, Cancer Prevention and Control Program and Co-Director, Community Outreach & Engagement, Georgetown Lombardi
Director, Cancer Prevention Precision Control Institute, Center for Discovery and Innovation, Hackensack Meridian Health, NJ
Lecture Series Presented by Georgetown Lombardi Comprehensive Cancer Center
Lisa Carter-Bawa, PhD, MPH, APRN, ANP-C, FAAN is a behavioral scientist with nearly two decades of clinical experience as an adult nurse practitioner.
Carter-Bawa was inducted as a Fellow in the American Academy of Nursing for her work in patient-clinician communication in complex cancer screening decisions in 2018. She is currently the Director of the Cancer Prevention Precision Control Institute at the Center for Discovery & Innovation (CDI) at Hackensack Meridian Health in New Jersey. She is also a Co-Leader of the Cancer Prevention & Control Program and Co-Director of Community Outreach & Engagement for the Georgetown Lombardi Comprehensive Cancer Center consortium. She also holds an Affiliate Investigator appointment at Kaiser Permanente Washington Health Research Institute in Seattle. Prior to joining CDI, she was an Associate Attending Behavioral Scientist and the Associate Research Director of Tobacco Research at Memorial Sloan Kettering Cancer Center with a parallel appointment as Associate Professor of Population Health at Weill Cornell Medical College.
Carter-Bawa’s research focuses on understanding the many factors that influence the decision-making process in lung cancer screening decisions as well as actual screening behavior. She has a particular passion for understanding how stigma influences the decision to screen, or not, for lung cancer, and has been funded by multiple organizations including the National Cancer Institute and the American Lung Association. She has been a strong advocate of understanding the patient perspective in lung cancer screening and credits the many wonderful individuals who have been involved in her studies for shaping her perspective on research and care in lung cancer.
Carter-Bawa serves as the Chair of the Stigma & Nihilism Task Group of the American Cancer Society’s National Lung Cancer Roundtable. She is an appointed member of the Editorial Board of Nursing Research, the scientific journal of the American Academy of Nursing. She also serves as an executive board member of the Cancer Prevention and Control Board of the Centralized Institutional Review Board of the National Cancer Institute as well as many academic and national committees aimed at improving cancer prevention, early detection and decreasing inequities in care.